A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer
Clinical trial NCT06758544 · RECRUITING
Trial details
- NCT number
- NCT06758544
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-17
- Primary completion
- 2026-09-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.